NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2010 Nov; 16(11):1467-503.
-
Hematologic Neoplasms
-
Hematopoietic Stem Cell Transplantation
-
Hodgkin Disease
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Leukemia, Myeloid, Acute
-
Lymphocyte Transfusion
-
Lymphoma, Non-Hodgkin
-
Multiple Myeloma
-
Neoplasm Recurrence, Local
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma
-
Recurrence
-
Transplantation, Homologous
-
Treatment Failure